封面
市场调查报告书
商品编码
1461278

週边血管器械市场,依产品类型、最终用户、地理位置

Peripheral Vascular Devices Market, By Product Type, By End User, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 185 Pages | 商品交期: 2-3个工作天内

价格
简介目录

预计2024年全球週边血管器械市值为126.8亿美元,预计2031年将达到194.5亿美元,2024年至2031年年复合成长率(CAGR)为6.3%。

报告范围 报告详情
基准年: 2023年 2023/2024 年市场规模: 126.8 亿美元
历史数据: 2019年至2023年 预测期: 2024年至2031年
预测期间 2023/2024 至 2030/2031 年复合成长率: 6.30% 2030/2031 价值预测: 194.5 亿美元
週边血管器械市场占有率 (%)(按地区),2024 年
週边血管器械市场 - IMG1

由于老年人口的增加和生活方式疾病的流行,全球週边血管器械市场在过去几年中一直稳定成长。週边血管装置主要用于诊断和治疗週边动脉疾病(PAD),这种疾病的特征是动脉狭窄,减少流向四肢的血流。专注于药物洗脱支架和评分球囊导管等先进技术开发的研究活动不断增加,预计将对预测期内的市场扩张产生积极影响。已开发经济体有利的报销情况以及对早期诊断的认识不断增强正在补充市场的成长。然而,高昂的治疗成本以及一定的程序和严格的监管审批是阻碍市场成长的一些主要因素。

市场动态:

全球週边血管器械市场的成长主要受到以下因素的推动:易患慢性病的老年人口不断增加,糖尿病、肥胖等生活方式疾病的患病率不断上升,导致外周动脉疾病,以及不断增加的创新器械开发研究倡议。糖尿病患者感染 PAD 的高风险增加了对有效诊断和介入手术的需求,从而刺激了对週边血管装置的需求。然而,技术先进的设备和治疗程序的高成本以及新产品审批的严格监管政策是限制市场成长的主要挑战。同时,主要参与者正在进行的引入生物可吸收支架和高效药物输送系统的研发活动在预测期内为市场参与者提供了利润丰厚的机会。

研究的主要特点:

  • 该报告对全球週边血管器械市场进行了深入分析,并提供了以2023年为基准年的预测期(2024-2031年)的市场规模(十亿美元)和年复合成长率(CAGR%)。
  • 它阐明了不同细分市场的潜在收入机会,并解释了该市场有吸引力的投资主张矩阵。
  • 这项研究还提供了有关市场驱动因素、限制因素、机会、新产品发布或批准、市场趋势、区域前景以及主要参与者采取的竞争策略的重要见解。
  • 它根据以下参数描述了全球週边血管器械市场的主要参与者——公司亮点、产品组合、主要亮点、财务表现和策略。
  • 该报告的见解将使行销人员和公司管理当局能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
  • 全球週边血管器械市场报告迎合了该行业的各个利益相关者,包括投资者、供应商、产品製造商、分销商、新进业者和财务分析师。
  • 利害关係人可以透过用于分析全球週边血管器械市场的各种策略矩阵轻鬆做出决策。

目录

第一章:研究目标与假设

  • 研究目标
  • 假设
  • 缩写

第 2 章:市场范围

  • 报告说明
    • 市场定义和范围
  • 执行摘要
  • Coherent Opportunity Map (COM)

第 3 章:市场动态、法规与趋势分析

  • 市场动态
    • 司机
    • 限制
    • 市场机会
  • 影响分析
  • 市场走向
  • 最近的发展
  • 收购和合作场景
  • 技术概览
  • 监管场景
  • PEST分析

第 4 章:全球週边血管器材市场 - 冠状病毒 (COVID-19) 大流行的影响

  • 整体影响
  • 对供需的影响
  • COVID-19 对市场的影响

第 5 章:全球週边血管器材市场,依产品类型,2019 - 2031 年(十亿美元)

  • 概述
  • 週边血管支架
  • 週边腔内血管成形术球囊导管
  • PTA导丝
  • 斑块切除装置
  • 慢性完全闭塞装置
  • 主动脉支架
  • 合成手术移植物
  • 其他的

第 6 章:全球週边血管器械市场,按最终用户划分,2019 - 2031 年(十亿美元)

  • 概述
  • 医院
  • 专科诊所
  • 门诊手术中心
  • 其他的

第 7 章:2019 - 2031 年全球週边血管器材市场(按地区)(十亿美元)

  • 介绍
  • 北美洲
  • 我们
  • 加拿大
  • 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 拉丁美洲其他地区
  • 欧洲
  • 英国
  • 德国
  • 义大利
  • 法国
  • 西班牙
  • 俄罗斯
  • 欧洲其他地区
  • 亚太地区
  • 中国
  • 印度
  • 日本
  • 东协
  • 澳洲
  • 韩国
  • 亚太地区其他地区
  • 中东
  • 海湾合作委员会
  • 以色列
  • 中东其他地区
  • 非洲
  • 北非
  • 中非
  • 南非

第 8 章:竞争格局

  • Abbot Laboratories
  • Boston Scientific Corporation
  • Angioscore
  • Emboline Inc.
  • Becton Dickinson, and Company
  • Cook Group Inc.
  • Cordis Corporation
  • Covidien PLC
  • Edward Lifesciences Corporation
  • Medtronic Plc
  • St. Jude Medical
  • Bayer AG
  • Teleflex Medical
  • Koninklijke Philips N.V.
  • Cardio Flow, Inc.

第 9 章:分析师观点

  • 命运之轮
  • 分析师观点
  • 连贯的机会图

第 10 章:参考文献与研究方法

  • 参考
  • 研究方法论
简介目录
Product Code: CMI391

Global peripheral vascular devices market is estimated to be valued at USD 12.68 Bn in 2024 and is expected to reach USD 19.45 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 6.3% from 2024 to 2031.

Report Coverage Report Details
Base Year: 2023 Market Size in 2023/2024: US$ 12.68 Bn
Historical Data for: 2019 to 2023 Forecast Period: 2024 to 2031
Forecast Period 2023/2024 to 2030/2031 CAGR: 6.30% 2030/2031 Value Projection: US$ 19.45 Bn
Peripheral Vascular Devices Market Share (%), By Region, 2024
Peripheral Vascular Devices Market - IMG1

Global peripheral vascular devices market has been witnessing steady growth over the past few years owing to increasing geriatric population and prevalence of lifestyle diseases. Peripheral vascular devices are majorly used in diagnosis and treatment of peripheral artery disease (PAD), a condition characterized by narrowed arteries reducing blood flow to limbs. Rising research activities focusing on development of advanced technologies such as drug-eluting stents and scoring balloon catheters is expected to positively influence the market expansion during the forecast period. Favorable reimbursement scenario in developed economies and growing awareness regarding early diagnosis are supplementing the market growth. However, high cost of treatment accompanied with certain procedures and strict regulatory approvals are some of the major factors impeding the market growth.

Market Dynamics:

Global peripheral vascular devices market growth is primarily driven by increasing geriatric population prone to chronic diseases, growing prevalence of lifestyle diseases such as diabetes, obesity leading to peripheral artery disease as well as rising research initiatives for development of innovative devices. High risk of contracting PAD in diabetic patients boosts the need for effective diagnostic and interventional procedures, thereby, fueling demand for peripheral vascular devices. However, high cost of technologically advanced devices and treatment procedures along with stringent regulatory policies for new product approvals are major challenges restraining the market growth. Meanwhile, ongoing research & development activities embarked by key players to introduce bio-absorbable stents and efficient drug delivery systems present lucrative opportunities for market players over the forecast period.

Key Features of the Study:

  • This report provides in-depth analysis of the global peripheral vascular devices market, and provides market size (USD BN) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year.
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global peripheral vascular devices market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study includes Abbott Laboratories, Boston Scientific Corporation, Angioscore, Emboline Inc., Becton Dickinson and Company, Cook Group Inc., Cordis Corporation, Covidien PLC, Edward Lifesciences Corporation, Medtronic Plc, St. Jude Medical, Bayer AG, Teleflex Medical, Koninklijke Philips N.V., and Cardio Flow, Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • Global peripheral vascular devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global peripheral vascular devices market.

Detailed Segmentation-

  • Product Type:
    • Peripheral Vascular Stents
    • Peripheral Transluminal Angioplasty Balloon Catheters
    • PTA Guidewires
    • Atherectomy Devices
    • Chronic Total Occlusion Devices
    • Aortic Stents
    • Synthetic Surgical Grafts
    • Others
  • End User:
    • Hospitals
    • Specialty Clinics
    • Ambulatory Surgical Centers
    • Others
  • Region:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Company Profiles:
    • Abbott Laboratories
    • Boston Scientific Corporation
    • Angioscore
    • Emboline Inc.
    • Becton Dickinson and Company
    • Cook Group Inc.
    • Cordis Corporation
    • Covidien PLC
    • Edward Lifesciences Corporation
    • Medtronic Plc
    • Jude Medical
    • Bayer AG.
    • Teleflex Medical
    • Koninklijke Philips N.V.
    • Cardio Flow, Inc.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Product Type
    • Market Snapshot, By End User
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Market Trends
  • Recent Developments
  • Acquisitions and Partnerships Scenario
  • Technology Overview
  • Regulatory Scenario
  • PEST Analysis

4. Global Peripheral Vascular Devices Market- Impact of Coronavirus (COVID-19) Pandemic

  • Overall Impact
  • Impact on Supply and Demand
  • COVID-19 Impact on the market

5. Global Peripheral Vascular Devices Market, By Product Type, 2019 - 2031, (USD BN)

  • Overview
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2019 - 2031
    • Segment Trends
  • Peripheral Vascular Stents
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD BN)
  • Peripheral Transluminal Angioplasty Balloon Catheters
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD BN)
  • PTA Guidewires
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD BN)
  • Atherectomy Devices
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD BN)
  • Chronic Total Occlusion Devices
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD BN)
  • Aortic Stents
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD BN)
  • Synthetic Surgical Grafts
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD BN)
  • Others
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD BN)

6. Global Peripheral Vascular Devices Market, By End User, 2019 - 2031, (USD BN)

  • Overview
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2019 - 2031
    • Segment Trends
  • Hospitals
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD BN)
  • Specialty Clinics
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD BN)
  • Ambulatory Surgical Centers
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD BN)
  • Others
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD BN)

7. Global Peripheral Vascular Devices Market, By Region, 2019 - 2031, (USD BN)

  • Introduction
    • Market Share Analysis, By Region, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, For Region, 2019-2031
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD BN)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD BN)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD BN)
  • U.S.
  • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD BN)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD BN)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD BN)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD BN)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD BN)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD BN)
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD BN)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD BN)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD BN)
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD BN)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD BN)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD BN)
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD BN)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD BN)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (USD BN)
  • North Africa
  • Central Africa
  • South Africa

8. Competitive Landscape

  • Abbot Laboratories
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Boston Scientific Corporation
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Angioscore
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Emboline Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Becton Dickinson, and Company
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Cook Group Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Cordis Corporation
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Covidien PLC
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Edward Lifesciences Corporation
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Medtronic Plc
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • St. Jude Medical
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Bayer AG
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Teleflex Medical
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Koninklijke Philips N.V.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Cardio Flow, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies

9. Analyst View

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

10. References and Research Methodology

  • References
  • Research Methodology
  • About us and Sales Contact